Telix Pharmaceuticals Competitors and Similar CompaniesClear all
Telix Pharmaceuticals's competitors and similar companies include ASLAN Pharmaceuticals, Plus Therapeutics, Leap Therapeutics and Teon Therapeutics.
 Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. |  ASLAN Pharmaceuticals ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market. |  Plus Therapeutics Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases. |  Leap Therapeutics Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics. |  Teon Therapeutics Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity. | |
Founding Date | Founding Date 2015 | Founding Date N/A | Founding Date 1996 | Founding Date 2011 | Founding Date 2017 |
Type | Type Public | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations SG HQ Collingwood, AU | Locations Austin, US HQ San Antonio, US | Locations Cambridge, US HQ | Locations Redwood City, US HQ | |
Employees | Employees 415 | Employees 35 | Employees 1721% increase | Employees 688% decrease | Employees 6 |
Valuation ($) | Valuation ($) 4.6 b | Valuation ($) N/A | Valuation ($) 8 m | Valuation ($) 176.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $803.8m (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $5.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $356m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $449m (FY, 2025) | Gross profit $12m (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($7.1m) (FY, 2025) | Net income ($44.2m) (FY, 2023) | Net income ($22.4m) (FY, 2025) | Net income $4.8m (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 23m (almost 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 30m (over 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 100m | Total funding raised $ 71.9m | Total funding raised N/A | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
ASLAN Pharmaceuticals
HQ
SG
Employees
35
ASLAN Pharmaceuticals is a clinical-stage oncology-focused biotechnology company developing novel therapeutics for the global healthcare market.
View companyPlus Therapeutics
HQ
Austin, US
Employees
17↑ 21% increase
Plus Therapeutics is a pharmaceutical company focused on the development of treatments for patients battling cancer and other life-threatening diseases.
View companyLeap Therapeutics
HQ
Cambridge, US
Employees
6
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
View companyTeon Therapeutics
HQ
Redwood City, US
Employees
6
Teon Therapeutics is a biopharmaceutical company that discovers and develops oral cancer medications for restoring anti-tumor immunity.
View company